Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PHARMAX AS
AS
Active
Org 925603988
Vestlia 1, 1592 Våler I Østfold
Retail sale of pharmaceutical products · NACE 4773
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-3% vs 2023
Equity ratio
49.6%
Financial strength
Net profit 2024
NOK 652K
+6697% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -10K
-3%
Net profit
NOK 652K
+6697%
Total assets
NOK 1,3M
+102%
Equity
NOK 650K
+52763%
Employees
0
—
Company information
Legal name
PHARMAX AS
Org number
925603988
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
8. september 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Eie og drive apotek og relaterte aktiviteter.
Contact
Address
Vestlia 1, 1592 Våler I Østfold
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Våler (Viken)
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
0
0
0
0
Staff expenses
−0
−0
−0
−0
EBITDA
−6
−10
−10
−10
Depreciation & amort.
−0
−0
−0
−0
EBIT
−6
−10
−10
−10
Net financials
0
0
0
662
Profit before tax
−6
−10
−10
652
Tax
−0
−0
−0
−0
Net profit
−6
−10
−10
652
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
655
767
650
1 312
Equity
18
9
−1
650
Long-term debt
517
517
300
0
Short-term debt
120
242
352
662
Total debt
637
759
652
662
Financial ratios
5-year trend
EBITDA margin
-1012900.0%
This company
15.8%
Market median
-6410859% vs market
2021
2024
Equity ratio
49.6%
This company
38.2%
Market median
+30% vs market
2021
2024
Return on equity
100.2%
This company
18.4%
Market median
+445% vs market
2021
2024
Net profit margin
65162100.0%
This company
8.1%
Market median
+804470270% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
WA
Waqar Ahmed
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KK
Komal Khan
Board of Directors
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Rubina Ali
Individual
18%
18%
2022
Akhtar Hussain
Individual
18%
18%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
PHARMAX AS
(this company)
CORVUS AS
Board network connections
Board members of PHARMAX AS also hold positions in
0
other companies.
Person
Role here
Other companies
Waqar Ahmed
Chief Executive Officer
0 companies
Komal Khan
Board of Directors
0 companies